@ktkadakia

Resident @MGHMedicine

Joined August 2018
  • Tweets894
  • Following1K
  • Followers874
164Media
Kushal Kadakia, MD retweeted
JACC Journals@JACCJournalsJul 29
Direct-to-patient prescription platforms: cheaper meds but more concerns for fragmented care, medication safety, adherence, and continuity of care. jacc.org/doi/10.1016/j.jacc.… #JACC @KavyaMShah @ktkadakia @kardiologykazi @rwyeh @rkwadhera
8
26
4,532
Kushal Kadakia, MD retweeted
NEJM AI@NEJM_AIJul 23
Perspective by Kushal T. Kadakia, MD, MSc (@ktkadakia), and Harlan M. Krumholz, MD, SM (@hmkyale): Adoption of Artificial Intelligence–Based End Points — A New Era for Clinical Trials nejm.ai/4wkloTl
A quote from a Perspective published in the NEJM AI reads as follows: “These tools hold transformative potential for clinical research if their use is grounded in rigorous evidence, performance is continuously monitored, and processes and regulations evolve to support innovation responsibly.” The Perspective is titled “Adoption of Artificial Intelligence–Based End Points — A New Era for Clinical Trials” and the authors are Kushal T. Kadakia, M.D., M.Sc., and Harlan M. Krumholz, M.D., S.M. The background color is dark blue and includes the NEJM AI logo.

ALT A quote from a Perspective published in the NEJM AI reads as follows: “These tools hold transformative potential for clinical research if their use is grounded in rigorous evidence, performance is continuously monitored, and processes and regulations evolve to support innovation responsibly.” The Perspective is titled “Adoption of Artificial Intelligence–Based End Points — A New Era for Clinical Trials” and the authors are Kushal T. Kadakia, M.D., M.Sc., and Harlan M. Krumholz, M.D., S.M. The background color is dark blue and includes the NEJM AI logo.

4
9
847
Coverage policy for breakthrough devices continues to evolve -- check out the latest from @mariojoze @KatieMPalmer in @statnews: statnews.com/2026/04/23/cms-…

CMS, FDA team up to fast-track reimbursement for breakthrough devices

Federal regulators are proposing a new, faster Medicare coverage pathway for medical devices deemed by the FDA as breakthroughs.

statnews.com
2
220
Nice coverage by @KatieMPalmer in @statnews about new proposed changes to breakthrough device reimbursement: statnews.com/2026/04/15/cms-…

CMS proposes rolling back breakthrough device payment flexibilities

CMS is proposing to repeal a pathway that allows breakthrough devices to get supplementary payments.

statnews.com
172
Kushal Kadakia, MD retweeted
Adith Arun
@aditharun_Mar 16
Work from @ktkadakia @hmkyale and I in a recent JACC report attempt to characterize the relationship between inflation-adjusted spending and mortality rate in cardiovascular disease. "The divergence between rising spending and stagnating mortality raises fundamental questions about how resources are being deployed and what is needed to resume progress in cardiovascular health." Full report: jacc.org/doi/10.1016/j.jacc.… [2/2]
1
1
407
Kushal Kadakia, MD retweeted
NEJM
@NEJMJan 16
Congress is considering bills that would substantially expand Medicare coverage of certain products. The authors of a new Perspective argue that the legislation could undermine CMS’s authority to implement evidence-based coverage policies. Read the Perspective by K.T. Kadakia (@ktkadakia) et al.: nej.md/3LMJFj4
Perspective "With the proposed legislation, Congress seeks to correct a perceived error of omission: the withholding of purportedly innovative devices from patients." "Automatic Medicare Coverage for New Medical Technologies — Here We Go Again" by K.T. Kadakia et al.

ALT Perspective "With the proposed legislation, Congress seeks to correct a perceived error of omission: the withholding of purportedly innovative devices from patients." "Automatic Medicare Coverage for New Medical Technologies — Here We Go Again" by K.T. Kadakia et al.

3
12
9,275
Nice analysis by @KatieMPalmer in @statnews on the debate before Congress regarding Medicare coverage of breakthrough devices: statnews.com/2026/01/14/medi…

Should Medicare automatically pay for medical devices that the FDA deems 'breakthrough'?

Questions about cost and patient benefit loom as Congress considers automatic Medicare coverage for 'breakthrough' medical devices.

statnews.com
1
2
4
482
Today, @JACCJournals & @ACCinTouch release #JACCStats: the first edition of a new, annual report on US CV health. Kudos to @rkwadhera, @lmhcurtis, and @hmkyale for their leadership: clarifying where we are to create accountability for where we go next jacc.org/doi/10.1016/j.jacc.…?

Cardiovascular Statistics in the United States, 2026: JACC Stats

jacc.org
3
15
1,310
How should Medicare cover emerging technologies? In @NEJM, we analyze the tension lawmakers are facing between access, clinical uncertainty, and cost as Congress once again debates this question (1/9) cc: @Yale_CRRIT @HouseCommerce @SenateFinance @MedTechDive @KatieMPalmer
1
5
16
702
more replies
(8/9) We offer alternative approaches to reform, including: -- Expanding Medicare's existing transitional coverage pathway -- Broadening transitional coverage eligibility to include diagnostics like MCEDs -- Improving @US_FDA/@CMSGov coordination for evidence generation
1
152
(9/9) We believe access and evidence can progress in tandem. For more, check out the article @NEJM nejm.org/doi/full/10.1056/NE… @hmkyale @jsross119 @reshmagar @RFRedberg @rwyeh @Yale_CRRIT @RAPSorg @harvardmed @PeterNeumann11 @LizzyLaw_ @statnews @MedTechDive @TCTMD @LincolnAlumni

Automatic Medicare Coverage for New Medical Technologies — Here We Go Again | NEJM

Congress is considering bills that would substantially expand Medicare coverage of certain products. The legislation could undermine CMS’s authority to implement evidence-based coverage policies.

nejm.org
187
"Medical school is a place not only for technical instruction but also for moral formation; becoming a doctor means adopting a way of thinking and also a way of behaving." -- fitting post-call & end-of-the-year reading from @DhruvKhullar @mghmedres newyorker.com/culture/2025-i…

The Role of Doctors Is Changing Forever

Some patients don’t trust us. Others say they don’t need us. It’s time for us to think of ourselves not as the high priests of health care but as what we have always been: healers.

newyorker.com
2
419
(1/9) Last week, the @USGAO published the results of its yearlong audit of @US_FDA's medical device recall process. The results underscore the need for action on medical device safety: gao.gov/products/gao-26-1076…

Medical Device Recalls: HHS and FDA Should Address Limitations in Oversight of Recall Process

The Food and Drug Administration monitors the safety of about 200,000 medical devices—such as pacemakers and joint replacements. From 2020 to 2024...

gao.gov
1
3
1
508
more replies
(8/9) I am proud that 2 of the 8 studies @USGAO included as shaping its report came from our team: -- UDIs in recalls led by @MaryamMooghali in @JAMAInternalMed -- Class I CV device recalls led by @seelaudia in @AnnalsofIM
1
1
146
(9/9) Check out the full @USGAO report here: gao.gov/assets/gao-26-107619… @mghmedres @harvardmed @Yale_CRRIT @hmkyale @jsross119 @reshmagar @rwyeh @LizzyLaw_ @debbiecenziper @sightsonwheels @propublica @PittsburghPG @statnews @SenatorDurbin @SenBlumenthal
1
155
Load more